In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hey, Get Out of My Space

Executive Summary

Chemdex Corp., a leading supplier of reagents and other products to laboratories and pharmaceutical R&D departments has acquired, a provider of purchasing services in high-tech, physician-preferred medical devices. With Chemdex's market cap soaring towards $1.5 billion, Promedix investors have seen their deal value increase over 50% beyond the $340 million at which it was first valued. The strategic rationale for this and similar kinds of deals is less obvious.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts